FARON PHARMACEUTICALS OY
Clinical-stage biopharmaceutical company developing immunotherapies for cancer.
FARN | IL
Overview
Corporate Details
- ISIN(s):
- FI4000153309
- LEI:
- 7437009H31TO1DC0EB42
- Country:
- Finland
- Address:
- Joukahaisenkatu 6, FI-20520 TURKU
- Website:
- https://faron.com/
- Sector:
- Manufacturing
Description
Faron Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer. The company pioneers macrophage-targeting therapies to leverage the patient's immune system, aiming to address unmet medical needs and improve outcomes. Its lead asset, bexmarilimab, is a first-in-class anti-Clever-1 antibody and a myeloid cell-targeting immunotherapy candidate. Bexmarilimab is being investigated in clinical trials as a potential therapy for hematological malignancies and solid tumors, often in combination with standard-of-care treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-12-01 08:00 |
Change in Faron’s Management Team
|
English | 13.5 KB | ||
| 2021-11-16 08:00 |
Faron to Present at Jefferies Conference 2021
|
English | 14.0 KB | ||
| 2021-11-09 08:00 |
Faron awarded EUR 3.8 Million in Arbitration Case
|
English | 14.3 KB | ||
| 2021-11-03 16:55 |
Cellular and Molecular Life Sciences Publication
|
English | 16.0 KB | ||
| 2021-10-07 08:00 |
Exercise of options
|
English | 11.8 KB | ||
| 2021-10-05 12:30 |
Holding(s) in Company
|
English | 49.1 KB | ||
| 2021-10-01 15:00 |
Registration of Placing Shares with Trade Register
|
English | 18.6 KB | ||
| 2021-10-01 08:00 |
Results of Placing and Issue Price
|
English | 29.9 KB | ||
| 2021-09-30 17:31 |
Proposed Issue and Placing of Shares
|
English | 47.3 KB | ||
| 2021-09-17 08:00 |
Presentation of Updated MATINS Data at ESMO
|
English | 24.1 KB | ||
| 2021-09-09 08:00 |
Faron Announces Presentation at ESMO Congress
|
English | 15.8 KB | ||
| 2021-09-07 08:00 |
Faron to Present at H.C. Wainwright Conference
|
English | 14.0 KB | ||
| 2021-08-26 08:00 |
Half-Year Financials, January 1 – June 30 2021
|
English | 144.1 KB | ||
| 2021-08-25 08:00 |
First Patient Dosed in Phase II/III COVID-19 Trial
|
English | 16.3 KB | ||
| 2021-07-28 08:00 |
Notice of Half-Year Report
|
English | 11.0 KB |
Automate Your Workflow. Get a real-time feed of all FARON PHARMACEUTICALS OY filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FARON PHARMACEUTICALS OY
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FARON PHARMACEUTICALS OY via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
